Core Viewpoint - Rosen Law Firm is reminding investors who purchased TransMedics Group, Inc. securities between February 28, 2023, and January 10, 2025, of the April 15, 2025, deadline to become lead plaintiffs in a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased TransMedics securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit alleges that TransMedics made materially false and misleading statements regarding its business practices, including the use of kickbacks and fraudulent overbilling, which led to regulatory risks and investor damages [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].
ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – TMDX